Company Tandem Diabetes Care, Inc.

Equities

TNDM

US8753722037

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:30:00 03/05/2024 BST 5-day change 1st Jan Change
44.72 USD +22.32% Intraday chart for Tandem Diabetes Care, Inc. +26.90% +51.18%

Business Summary

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.

Number of employees: 2,400

Sales per Business

USD in Million2022Weight2023Weight Delta
Supplies and Other
54.4 %
- - 407 54.4 % -
Pump
50.1 %
432 53.9 % 374 50.1 % -13.34%
Deferral for Tandem Choice Program
-3.4 %
-4 -0.4 % -25 -3.4 % +607.44%
Pump Rebate
-1.1 %
- - -8 -1.1 % -

Sales per region

USD in Million2022Weight2023Weight Delta
United States
74.2 %
589 73.5 % 555 74.2 % -5.76%
Non-United States
25.8 %
212 26.5 % 193 25.8 % -9.23%

Managers

Managers TitleAgeSince
Chief Executive Officer 68 28/02/13
Director of Finance/CFO 51 31/08/13
Compliance Officer 58 31/12/21
Chief Tech/Sci/R&D Officer - 25/04/21
Chief Tech/Sci/R&D Officer - 30/04/20
Chief Tech/Sci/R&D Officer - 31/08/19
Chief Administrative Officer 44 31/10/07
Chief Tech/Sci/R&D Officer 60 01/12/21
Director/Board Member 71 31/08/07
Corporate Officer/Principal - 11-12

Members of the board

Members of the board TitleAgeSince
Chairman 63 02/01/19
Director/Board Member 64 30/06/13
Director/Board Member 71 31/08/07
Chief Executive Officer 68 28/02/13
Director/Board Member 60 07/06/20
Director/Board Member 79 30/06/07
Director/Board Member 57 02/08/20
Director/Board Member 50 31/12/20
Director/Board Member 47 14/06/22
Director/Board Member 58 14/06/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 64,589,518 63,917,370 ( 98.96 %) 0 98.96 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
13.33 %
8,746,894 13.33 % 310 M $
Vanguard Fiduciary Trust Co.
10.70 %
7,021,906 10.70 % 249 M $
Capital Research & Management Co. (World Investors)
9.727 %
6,384,111 9.727 % 226 M $
Eminence Capital LP
7.878 %
5,170,451 7.878 % 183 M $
Fidelity Management & Research Co. LLC
4.536 %
2,977,274 4.536 % 105 M $
ArrowMark Colorado Holdings LLC
4.472 %
2,935,003 4.472 % 104 M $
Janus Henderson Investors US LLC
3.928 %
2,577,742 3.928 % 91 M $
Jennison Associates LLC
3.895 %
2,556,124 3.895 % 91 M $
2,274,566 3.466 % 81 M $
Bellevue Asset Management AG
3.036 %
1,992,317 3.036 % 71 M $

Company contact information

Tandem Diabetes Care, Inc.

12400 High Bluff Drive

92130, San Diego

+858 366 6900

http://www.tandemdiabetes.com
address Tandem Diabetes Care, Inc.(TNDM)
  1. Stock Market
  2. Equities
  3. TNDM Stock
  4. Company Tandem Diabetes Care, Inc.